Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01423006 · ClinicalTrials.gov registry record · NA
Pilot Study on Focal Prostate Radio-Frequency Ablation
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01423006: Completed NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT01423006 is a NA study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01423006, a NA study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This is a prospective pilot study. The purpose of this research study is to evaluate the safety and efficacy of focal Radio-Frequency Ablation (RFA) in men with low-risk, clinically localized prostate cancer.
Primary Outcome
The primary efficacy endpoint is negative biopsy rate at 6 months after focal bipolar RFA. Evaluable patients for this study will be those who complete up through the six month follow-up/evaluation procedure.
Interventions
- PROCEDURE Radio-Frequency Ablation (RFA) ENCAGE™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2011-08 |
| Est. Completion | 2013-03 |
| Phase | NA |
What the finished NCT01423006 record still lists
NCT01423006 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Radio-Frequency Ablation (RFA) ENCAGE™ is the first listed.
NCT01423006 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01423006 about?
NCT01423006 is a clinical study titled "Pilot Study on Focal Prostate Radio-Frequency Ablation". This is a prospective pilot study. The purpose of this research study is to evaluate the safety and efficacy of focal Radio-Frequency Ablation (RFA) in men with low-risk, clinically localized prostate cancer.
What is the current status of trial NCT01423006?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2011-08. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01423006?
The interventions under investigation include: Radio-Frequency Ablation (RFA) ENCAGE™ (PROCEDURE).
Who is sponsoring clinical trial NCT01423006?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01423006's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia